Price movement over the last 24 hours
Align Technology, Inc. vs iShares MSCI South Africa ETF — how do they compare? Align Technology, Inc. trades at $176.01 (market cap $13.27B), while iShares MSCI South Africa ETF trades at $62.52. The key difference: Align Technology, Inc. is trading nearer its 52-week high, iShares MSCI South Africa ETF nearer its low. Which is the better fit depends on your goals.
| ALGN | EZA | |
|---|---|---|
Market Cap | $13.27B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $207.19 | $81.60 |
52-Week Low | $124.88 | $52.86 |
Enterprise Value | $12.32B | — |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $185.22, up 0.38% today, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results expected soon. Revenue remains stable around $4.0B, supported by a 67.57% gross margin and positive cash flow trends. Recent news highlights global expansion and product innovation, including a new manufacturing facility in India.
Outlook is positive with a $220.75 consensus price target, though risks include regulatory scrutiny from the European Commission and competitive pressures. The stock's valuation at a P/E of 31.65 reflects growth expectations, but investors should monitor execution on international growth and demand stability in North America.
EZA trades at $64.63, up 0.98% on the day, but technical indicators signal a bearish trend with moving averages pointing lower. The stock faces resistance near $65 and has support at $63. A dividend of $1.43 is scheduled for payment on June 22, 2026. Recent news highlights South Africa's extended fuel tax cut, which may impact regional economic conditions relevant to the fund's holdings.
The outlook remains cautious due to weak technical momentum and lack of fundamental data. Risks include exposure to South African economic policies and commodity volatility. Investors should await updated financials for a clearer valuation picture, as current metrics are unavailable.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →EZA is a country-specific ETF that tracks the South African equity market. It provides exposure to large and mid-cap companies across key sectors like materials and financials, with top holdings such as AngloGold Ashanti and Naspers.
Read more on EZA →